Renaissance Technologies
DRTX

Renaissance Technologies’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Renaissance Technologies’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-66,200
Closed -$1.13M – 3146
2014
Q2 		$1.13M Buy
66,200
+5,900
+10% +$87.8K ﹤0.01% 2003
2014
Q1 		$812K Buy
+60,300
New +$790K ﹤0.01% 2168

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Renaissance Technologies's DRTX Position: Q3 2014 in Review

Renaissance Technologies sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q3 2014, closing a stake of 66,200 shares — an estimated $1.13M sold.

Renaissance Technologies first reported a position in DRTX in Q1 2014 and held it in 2 quarters. The position peaked at $1.13M in Q2 2014. 70 funds tracked by Wall St. Rank hold DRTX as of Q3 2014.

  • Renaissance Technologies reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Renaissance Technologies sold 66,200 DURATA THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $1.13M.
  • Renaissance Technologies first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Renaissance Technologies's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.13M in Q2 2014.
  • 70 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Renaissance Technologies's 13F filing for Q3 2014, filed 12 Nov 2014.